Press Releases

Varian Expects to Benefit from the Extension of Medical Linear Accelerators Tariff Exclusion in China

Varian (NYSE: VAR) has received notice from the Customs Tariff Commission of the State Council of China that the first exclusion of the additional tariffs China imposed on US products will expire...

Varian Drives Next Evolution of Proton Treatment Planning with Eclipse v16.1

Highlights: Integration of Dual Energy CT (DECT) images in the Eclipse planning process reduces range uncertainty and helps clinicians' spare healthy tissue. Graphics Processing Unit (GPU)...

Varian Announces Appointment of Chris Toth as President and Chief Operating Officer

Varian (NYSE: VAR) today announced the following leadership appointments, effective October 5, 2020: Chris Toth, Varian Oncology Systems President, has been appointed to the newly created role of...

Varian Announces Goshen Center for Cancer Care Treats First Patient with Ethos® Therapy, Expanding Access to Personalized Cancer Care

Varian (NYSE: VAR) today announced the Goshen Center for Cancer Care in Goshen, Ind., treated its first patient with Ethos™ therapy, marking the first availability of this advanced cancer...

Germany's first Ethos Therapy Ordered by the German Cancer Research Center

Varian (NYSE: VAR) today announced the German Cancer Research Center (DKFZ) in Heidelberg has ordered Germany's first Ethos™ therapy, an Adaptive Intelligence™ solution. This artificial...

Varian Reports Results for Third Quarter of Fiscal Year 2020

Third Quarter 2020 Summary

Varian to Combine with Siemens Healthineers in $16.4 Billion All-Cash Transaction

/PRNewswire/ -- Varian (NYSE: VAR) today announced that it has entered into a definitive agreement to combine with Siemens Healthineers AG (Frankfurt: SHL) in an all-cash transaction valued at $16.4 billion on a fully diluted basis.

Varian Announces Third Quarter Fiscal Year 2020 Earnings Release Date

Varian (NYSE: VAR) today announced its third quarter fiscal year 2020 earnings release date. The Company will report results for the third quarter of fiscal year 2020 after market close on...

Varian Wins "Best After-Sales Service Award for Radiotherapy Products" in China For Third Year In A Row

Varian (NYSE: VAR) today announced it received the "Best After-Sales Service Award for Radiotherapy Products" in the 2019 Chinese Medical Devices Industry Data and After-Sales Service Survey for...

Long-Term Results from SABR-COMET Further Demonstrate Effectiveness of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Metastatic Cancers

Long-term results of the Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Cancers (SABR-COMET) study published June 2, 2020 in the Journal of Clinical Oncology...